DEA Proposes Special Registration System For Remote Prescribing Of Controlled Substances

On January 17, 2025, the U.S. Drug Enforcement Administration (DEA) issued a proposed rule to create special registrations for telemedicine and limited state telemedicine registrations that would allow consumers to receive prescribed medications through telemedicine visits without ever having an in-person medical evaluation from a medical professional. The three-tiered special registration rule will require the establishment of a national Prescription Drug Monitoring Program (PDMP) that would allow pharmacists and medical professionals access to view an individual’s history with prescribed medications. The goal of a national PDMP is to help the health care sector prevent abuse and . . .